Literature DB >> 21743407

Clinico-therapeutic management of osteoradionecrosis: a literature review and update.

Javier Silvestre-Rangil1, Francisco-Javier Silvestre.   

Abstract

In the management of head and neck cancer, radiotherapy is usually a coadjuvant to surgery, or is applied on a palliative basis. The most important complication of such radiotherapy is osteoradionecrosis, which manifests as an area of exposed necrotic bone in the maxillae or mandible that fails to heal during at least three months. In most cases osteoradionecrosis gradually progresses, becoming more extensive and painful, and its late manifestations comprise infection and pathological fracture. The present study provides a literature review and update on the risk factors underlying osteoradionecrosis, its clinical and diagnostic particulars, prevention, and most widely accepted treatment options, as well as new possibilities relating to clinical management of the disorder. Lastly, a new early management protocol is proposed based on the current consensus criteria relating to maxillary osteonecrosis secondary to treatment with bisphosphonates, together with the adoption of new therapies supported by increased levels of evidence.

Entities:  

Mesh:

Year:  2011        PMID: 21743407     DOI: 10.4317/medoral.17257

Source DB:  PubMed          Journal:  Med Oral Patol Oral Cir Bucal        ISSN: 1698-4447


  12 in total

Review 1.  Osteoradionecrosis of the Jaws: Clinico-Therapeutic Management: A Literature Review and Update.

Authors:  Koteswara Rao Nadella; Rama Mohan Kodali; Leela Krishna Guttikonda; Ashok Jonnalagadda
Journal:  J Maxillofac Oral Surg       Date:  2015-03-10

Review 2.  A review of dental treatment of head and neck cancer patients, before, during and after radiotherapy: part 2.

Authors:  H Jawad; N A Hodson; P J Nixon
Journal:  Br Dent J       Date:  2015-01       Impact factor: 1.626

3.  Osteoradionecrosis of the hyoid bone--a novel application of the Sonopet ultrasonic aspirator.

Authors:  Amarbir Singh Gill; Arjun S Joshi
Journal:  BMJ Case Rep       Date:  2014-09-22

4.  Oral hygiene in patients with oral cancer undergoing chemotherapy and/or radiotherapy after prosthesis rehabilitation: protocol proposal.

Authors:  B Rapone; G M Nardi; D DI Venere; F Pettini; F R Grassi; M Corsalini
Journal:  Oral Implantol (Rome)       Date:  2017-02-14

5.  A Prospective Biopsychosocial Investigation Into Head and Neck Cancer Caregiving.

Authors:  Chandylen L Nightingale; Deidre B Pereira; Barbara A Curbow; John R Wingard; Giselle D Carnaby
Journal:  Biol Res Nurs       Date:  2016-07-28       Impact factor: 2.522

6.  Case report: chronic inflammatory ulcer and osteoradionecrosis of the skull following radiotherapy in early childhood.

Authors:  Birte Julia Siegmund; Jan Rustemeyer
Journal:  Oral Maxillofac Surg       Date:  2019-04-23

7.  Treatment of osteoradionecrosis of mandible with bone marrow concentrate and with dental pulp stem cells.

Authors:  K Manimaran; S Sankaranarayanan; V R Ravi; S Elangovan; M Chandramohan; S Mahendra Perumal
Journal:  Ann Maxillofac Surg       Date:  2014 Jul-Dec

8.  Prophylactic Use of Pentoxifylline and Tocopherol in Patients Undergoing Dental Extractions Following Radiotherapy for Head and Neck Cancer.

Authors:  Karun Aggarwal; Manish Goutam; Madhavi Singh; Neetu Kharat; Vandana Singh; Suyash Vyas; Harkanwal Preet Singh
Journal:  Niger J Surg       Date:  2017 Jul-Dec

9.  Clinical management of suppurative osteomyelitis, bisphosphonate-related osteonecrosis, and osteoradionecrosis: report of three cases and review of the literature.

Authors:  Eduardo Pereira Guimarães; Fernanda Rafaelly de Oliveira Pedreira; Bruno Correia Jham; Marina Lara de Carli; Alessandro Antônio Costa Pereira; João Adolfo Costa Hanemann
Journal:  Case Rep Dent       Date:  2013-10-07

10.  Osteoradionecrosis prevalence and associated factors: A ten years retrospective study.

Authors:  I-F Pereira; R-T Firmino; H-C Meira; B-C-E Vasconcelos; V-R-A-S Noronha; V-R Santos
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.